Email Share
Close
E-mail It

NOTE: Recipients' Email Address currently accepts only 5 email addresses separated by commas.

Publications

Publications

2008 Publications:

  1. Baik I, Lambe M, Liu Q, Chie L, Cnattingius S, Mucci L, Riman T, Ekbom A, Adami H-O, Hsieh C-C. Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationanwide cohort. Cancer Causes Control 2008;19:1131-1137. [700]
  2. Biggar RJ, Johansen JS, Smedby KE, Rostgaard K, Chang E, Adami HO, Glimelius B, Molin D, Hamilton-Dutoit S, Melbye M, Hjalgrim H. Serum YKL-40 and IL-6 levels in Hodgkin Lymphoma. Clin Cancer Res 2008;14:6974-78. [738]
  3. Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Hamberg H, Häggman M, Andersson S-O, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson J-E. Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Institute 2008;100:1144-1154. [721]
  4. Cnattingius S, Eloranta S, Adami HO, Axelsson O, Dickman PW, Hsieh CC, Mucci LA, Trichopoulos D, Lambe M, Johansson AL. Placental weight and risk of premenopausal epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2344-2349.  [739]
  5. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008 Jan 26;371:303-14. [645]
  6. Cooper ML, Adami HO, Grönberg H, Wiklund F, Green FR, Rayman MP. Interaction between SNPs in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 2008:68:10171-7.   [737]
  7. Fang F, Ye W, Fall K, Lekander M, Wigzell H, Sparén P, Adami HO, Valdimarsdóttir U. Loss of a child and the risk of amyotrophic lateral sclerosis.  Am J Epidemiol. 2008 Jan 15;167:203-10. [701]
  8. Gram I, Adami H-O, Braathen T, Lund E, Weiderpass E. Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 2008;122:647-652. [689]
  9.  Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindström S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW, Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet. 2008 Mar;40:281-3. [732]
  10. Ioannidis J, Adami H-O. Nested randomized trials in large cohorts and biobanks: Studying the Health Effects of life style factors. Epidemiology. 2008 Jan 19:75-82. [685] \
  11. Lagiou P, Hsieh CC, Trichopoulos D, Adami HO, Hall P, Chie L, Ekbom A. Neonatal growth and breast cancer risk in adulthood. Br J Cancer. 2008 Nov 4;99(9):1544-8. [747]
  12. Lindström S, Adami HO, Adolfsson J, Wiklund F. Y chromosome haplotypes and prostate cancer in Sweden. Clin Cancer Res 2008;14:6712-16.   [727]
  13.  Lu M, Ye W, Adami HO, Weiderpass E. Stroke incidence in women under 60 years related to alcohol intake and smoking habit. Cerebrovasc Dis 2008:25:517-525. [675]
  14. Luo J, Margolis KL, Adami HO, LaCroix A, Ye W. Obesity and risk of pancreatic cancer among postmenopausal women: the Women’s Health Initiative (United States). Br J Cancer 2008;99:527-531 [719]
  15. Luo J, Adami HO, Reilly M, Ekbom A, Nordenvall C, Ye W. Interpreting trends in pancreatic cancer incidence and mortality: a nation-wide study in Sweden 1960 to 2003. Cancer Causes Control. 2008 Feb;19:89-96. [702]
  16. Margolis KL, Luo J, Ye W, Adami HO for the Women’s Health Initiative Investigators. Four authors reply. Am J Epidemiol 2008;167:1016. [735]
  17. Mink P, Adami HO, Trichopoulos D, Britton N, Mandel J. Pesticides and prostate cancer: A review of epidemiologic studies with specific agricultural exposure information. Eur J Cancer Prev. 2008 Apr;17:97-110. [639]
  18. Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark J, Adami HO, Andersson SO, Andrén O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA.  Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Cancer Epidemiol Biomarkers Prev 2008;17:249-51.  [686]
  19. Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark J, Adami HO, Andersson SO, Andrén O, Eisenstien AS, Holmberg L, Huang W, Kantoff PW, Kim R, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Testing a multigene signature of prostate cancer death in the Swedish watchful waiting cohort. Cancer Epidemiol and Biomarkers Prev 2008;17:1682-8.  [745]
  20. Olsson M, Linström S, Häggkvist B, Adami HO, Bälter K, Stattin P, Ask B, Rane A, Ekström L, Grönberg H. The UGT2B17 gene deletion is not associated with prostate cancer risk.  The Prostate 2008:68:571-575. [731]
  21. Schöllkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Jensen IP, Vinner L, Glimelius B, Porwit A, Sunström C, Hansen M, Adami HO, Melbye M.  Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008;122:1885-1890.  [718]
  22. Schollkopf C, Melbye M, Munksgaard L, Rostgaard K, Riis J, Smedby KE, Glimelius B, Roos G, Hansen M, Adami HO, Hjalgrim H.  Borrelia Infection and risk of non-hodgkin lymphoma.  Blood 2008;11:5524-5529. [715]
  23. Schouten L, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom A, Fraser G, Freudenheim JL, Goldbohm RA, Hansinson SE, Lacey JV, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel A, Rodriguez C, Rohan TE, Ross J, Wolk A, Zhang S, Smith-Warner SA.  Height, body mass index and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2008;17:902-12.  [711]
  24. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andren O, Johnson LA, Tang J, Adami HO, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson SO, Varenhorst E, Johanson JE, Brown M, Golub TR, Rubin MA.  Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 2008;100:815-825. [723]
  25. Strohsnitter WC, Savarese TM, Low HP, Chelmow DP, Lagiou P, Lambe M, Edmiston K, Liu Q, Baik I, Noller KL, Adami HO, Trichopoulos D, Hsieh CC.  Correlation of umbilical cord blood hematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk.  Br J Cancer. 2008 Feb 12;98:660-3.  [720]
  26. Sun J, Zheng S, Wiklund F, Isaacs SD, Li G, Hsu FC, Kim ST, Liu W, Zhu Y, Stattin P, Adami HO, Wiley KE, Dimitrov L, Sun J, Li T, Turner AR, Adams TS, Adolfsson J, Johansson JE, Lowey J, Trock BJ, Partin AW, Walsh PC, Trent JM, Duggan D, Carpten J, Chang B, Grönberg H, Isaacs W, Xu J. Evidence for two independent prostate cancer risk - associated loci in the HNF1B gene at 17q12. Nat Genet 2008;40:1153-1155. [746]
  27.  Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P.  Early life events and conditions and breast cancer risk: from epidemiology to aetiology.  Int J Cancer 2008;122:481-485. [729]
  28. Troisi R, Lagiou P, Trichopoulos D, Xu B, Chie L, Stanczyk FZ, Potischman N, Adami HO, Hoover RN, Hsieh CC. Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates. Cancer Epidemiol Biomarkers Prev. 2008 Jan;17:224-31. [717]
  29. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;358:910-9. [725]
  30. Wiklund F, Trolle Lagerros Y, Chang E, Bälter K, Stattin P, Adami HO, Grönberg. H. Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden. Eur J Epidemiol 2008;23:739-746. [710]